Clarius Group LLC’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.11M | Buy |
617,535
+560,342
| +980% | +$2.82M | 0.18% | 59 |
|
|
2025
Q1 | $371K | Hold |
57,193
| – | – | 0.02% | 299 |
|
|
2024
Q4 | $420K | Hold |
57,193
| – | – | 0.03% | 250 |
|
|
2024
Q3 | $428K | Hold |
57,193
| – | – | 0.03% | 240 |
|
|
2024
Q2 | $509K | Hold |
57,193
| – | – | 0.04% | 212 |
|
|
2024
Q1 | $579K | Buy |
57,193
+7,182
| +14% | +$72.8K | 0.04% | 197 |
|
|
2023
Q4 | $503K | Sell |
50,011
-7,182
| -13% | -$72.3K | 0.04% | 235 |
|
|
2023
Q3 | $536K | Hold |
57,193
| – | – | 0.05% | 207 |
|
|
2023
Q2 | $1.4M | Hold |
57,193
| – | – | 0.11% | 99 |
|
|
2023
Q1 | $1.33M | Hold |
57,193
| – | – | 0.11% | 103 |
|
|
2022
Q4 | $1.45M | Hold |
57,193
| – | – | 0.13% | 95 |
|
|
2022
Q3 | $1.1M | Buy |
57,193
+18,514
| +48% | +$357K | 0.11% | 112 |
|
|
2022
Q2 | $985K | Sell |
38,679
-3,805
| -9% | -$96.9K | 0.1% | 126 |
|
|
2022
Q1 | $1.78M | Hold |
42,484
| – | – | 0.14% | 89 |
|
|
2021
Q4 | $1.78M | Sell |
42,484
-183
| -0.4% | -$7.66K | 0.14% | 89 |
|
|
2021
Q3 | $1.86M | Buy |
42,667
+5,722
| +15% | +$249K | 0.17% | 72 |
|
|
2021
Q2 | $1.75M | Buy |
36,945
+1,588
| +4% | +$75.1K | 0.16% | 79 |
|
|
2021
Q1 | $1.81M | Buy |
+35,357
| New | +$1.81M | 0.18% | 65 |
|